451-03-012 / 451-03-012
MRI in Clinical Practice Abstract
MRI in Clinical Practice: HFpEF With Normal NT-proBNP—Multiparametric CMR Confirms Diffuse Myocardial Fibrosis
Accepted
Full abstract & presentation
The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.
Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.
To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.
Log inReferences
1. Heidenreich PA, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. Circulation. 2022.
2. Buckley LF, et al. Low NT-proBNP levels in overweight/obese patients do not rule out HFpEF. ESC Heart Fail. 2018.
3. Kozhuharov N, et al. Clinical effect of obesity on NT-proBNP. Eur J Heart Fail. 2022.
4. Haaf P, et al. Cardiac T1 mapping & ECV in diffuse myocardial fibrosis. J Cardiovasc Magn Reson. 2017.
Cite this abstract
http://echo.ismrm.org/p/ISMRM2026/451-03-012